PHP 580 Pharmacoeconomics
|Coordinator/Primary Instructor||Dr. Paul Larrat (coordinator) and Dr. Stephen Kogut|
|Catalog Description||Introduction to methodologic approaches utilized in economic evaluation of drug use and therapy in community and managed care settings, and clinical trials, including the FDA approval process and liability issues. (Lec. 3) Pre: STA 307 or equivalent, or permission of instructor.|
|Estimated Enrollment||30 (Preference for P2 – P4, graduate students .)|
Detailed Course Description
Introduction to methodologic approaches utilized in economic and health outcomes evaluation of drug use and therapy in community and managed care settings, and in clinical trials. Regulatory, policy and legal implications of the research strategies will be discussed.
Group Project (30%)
Briefing Paper (25%) – A short (4 pages, single spaced, 12 font MAX) will be due by May 1. This paper must be succinct, properly referenced and effectively presented. You will be required to use the referencing method and manuscript formats common to the healthcare industry.
In-Class presentation (5%) – Throughout the semester, students will have the opportunity to present for 15-20 minutes on their topic. The effective use of PowerPoint (15 slides MAX) will be stressed.
Critical Thinking, Participation, and Professionalism (10%)